Patients’ personalities seem to affect their response to the COVID-19 pandemic. This study examined the association of personality traits and characteristics of Iranian COVID-19 outpatients with their compliance to nonmandatory quarantine orders. This cross-sectional study was conducted in 2020-2021 on 97 COVID-19 outpatients. The temperament and character inventory-revised short version (TCI-RS) and a self-report checklist assessing compliance with quarantine orders were used to collect data. SPSS was used to analyze the data and P < 0.05 was considered statistically significant. Of 142 patients who were contacted, 97 participated in the study (68% response rate). The mean age of patients was 39.21 ± 10.27 years and 54 (55.7%) of them were men. Compliance with quarantine orders was correlated with cooperativeness ( r = 0.33; P = 0.001), persistence ( r = 0.23, P = 0.020), self-transcendence ( r = 0.27, P = 0.006) and harm avoidance ( r = -0.26, P = 0.008). Linear regression analysis demonstrated persistence ( P = 0.034), cooperativeness ( P = 0.008) and being married ( P = 0.002) as predictors for following the quarantine orders. Lower levels of cooperativeness, persistence, self-transcendence, and higher levels of harm avoidance are associated with noncompliance with quarantine orders. These traits should be considered while persuasive communication to the public is formulated to recognize the target population and increase compliance with nonmandatory quarantine orders.
Background: Diabetes mellitus (DM) is the most common chronic disease. This disease is the main risk factor for fatal diseases such as myocardial infarction and stroke. As there is no cure for DM, an effective strategy must control it. Every attempt to control DM and patients’ outcomes require a surveillance system to consider the efficacy and safety measures. Fasa Registry on Diabetes mellitus (FaRD) is the first population-based registry for DM in Iran, which aims to provide an accurate description of social, mental health, clinical, and laboratory values of patients in order to consider the management patterns of these patients and discover the degree of adherence to the recommendations. Materials and Methods: The level of plasma glucose characterizes the diagnosis of diabetes (Type I and II). The pregnant women were excluded from this study. Three registrar nurses collected data from demographics, physical exams, past medical history, medication history, and laboratory findings. Results: The pilot phase included the first 381 patients, of which 257 (67.5%) were women, and 124 (32.5%) were men with a mean age of 57.54 ± 12.12 years among subjects, the 347 (94.5%) cases had DM type 2, and 20 (5.4%) ones had type 1. Conclusion: Based on our results, the characteristics of patients suffering from DM indicated that the jobless ones could not afford their medical expenditures; therefore, the majority of the patients were not adherent to the practice guidelines. The achievement of FaRD helps physicians and patients in improved management of the DM. The findings of this pilot study show the FaRD is feasible, and it will make a comprehensive population-based registry for DM in the region. [GMJ.2021;10:e2137]
Bruxism associated with antidepressant use is an under-recognized phenomenon. The use of citalopram has gained wide acceptance in the treatment of depression and anxiety disorders; however, the consumption of this medication during lactation and pregnancy has not been carefully characterized. There are limited studies about its side effects in the breastfeeding period. Here, we report a rare case of citalopram-induced sleep bruxism in a 9-month-old female breastfed infant whose mother used SSRI agent citaloporm for her anxiety disorder. Within 2 weeks of initiating her citalopram treatment, with a starting dose of 10 mg/day, the patient reported sleep bruxism in her infant. Thorough examinations of the infant were performed and no abnormal finding was reported. After ruling out other possible causes, the new-onset bruxism symptoms were attributed to the mother’s recent use of citalopram, which was discontinued thereafter. The infant’s symptoms of bruxism disappeared following the discontinuation of the medication by her mother. These findings and similar reports could draw more attention to bruxism or other possible symptoms in breastfed infants of mothers consuming psychotropic medications.
Background & Objective: Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a rare disease with a prevalence estimation of, 5 per, 100,000 individuals. Besides, it can highly be misdiagnosed with other psychiatric disorders. Case Presentation: We report a case of CADASIL in a 32-year-old Asian female presenting with schizophrenia symptoms such as auditory hallucination ،loosening of associations، persecutory delusions، referential delusions، decreased function, and complex hepatic hallucinations that the patient had said sometimes someone has intercourse with me since 2 years ago. After brain Magnetic Resonance Imaging (MRI) and gene checking, she showed up with NOTCH3 gene, besides Brain Magnetic resonance imaging confirmed the presence of CADASIL. Supportive treatments have been done and two years of following up showed a significant increase in patient life quality Conclusion: This case report demonstrates the challenges of CADASIL diagnosis in a patient with schizophrenia symptoms. The diagnosis should be considered in patients with schizophrenia symptoms. Hence, there is a need for timely diagnosis and management of this disorder.
Background: Many of women and pregnant women are front-line health care workers in the COVID-19 era and are worried about the possible impacts of COVID-19 on their fetus. Due to the pressure and high working load on the healthcare workers during the COVID-19 crisis, the healthcare workers were potentially at risk of different types of mental health disorders. Objective: We aimed to evaluate the correlation between mental health status and the level of COVID-19 related anxiety in pregnant healthcare workers in the COVID-19 era in Iran from August 2020 to December 2020. Methods: This cross-sectional study included 64 pregnant clinical residents, general physicians, nurses and other medical staff who worked in the hospitals in Iran, from August 2020 to December 2020 using an anonymous online survey available on Google Form platform. The online survey consisted of socio-demographic questions, pregnancy-related questions, and questions about medical/drug history. The Persian versions of General Health Questionnaire – 28 [GHQ-28], and Corona Disease Anxiety Scale [CDAS] were also filled by the participants. Results: The mean age and gestational age of the participants were 31.3±3.9 years, and 24.5±10.1 weeks respectively. Psychological problems were moderate [total score GHQ-28> 40] in 9.4% [n: 6] of the pregnant healthcare workers. The frequency of moderate/severe problems in the four subclasses, including somatic symptoms, anxiety/insomnia, social dysfunction, and depression were 9[14.1%], 25[39.0%], 7[10.9%], and 10[15.6%], respectively. According to CDAS, 26.5% of participants had moderate to severe COVID-19 related anxiety. COVID-19 related anxiety and its subclasses, physical and psychological, were significantly correlated with GHQ-28 total score and its subclasses, including somatic symptoms, anxiety/insomnia, social dysfunction, and depression among pregnant health care workers [P<0.01]. Conclusion: According to the results of the current study, over 25% of the pregnant health care workers have moderate to severe COVID-19 related anxiety; so, it is crucial for policymakers to focus on the mental health of the pregnant health care workers during the COVID-19 pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.